Limit the bleeding, limit the pain in total hip and knee arthroplasty.

Patients undergoing total hip or knee arthroplasty often sustain significant decreases in hemoglobin and hematocrit, despite modern techniques and shorter operating times. Reasons for the blood loss include raw bony surfaces, vascular inflammatory tissue, and fragile vessels in elderly patients. Acute postoperative anemia has numerous deleterious effects on patients, including delayed rehabilitation, exposure to allogeneic blood transfusions, higher complication rates, and increased pain. The ability to limit the amount of postoperative bleeding may reduce the amount of postoperative pain that patients experience, ultimately resulting in greater patient satisfaction and smoother postoperative rehabilitation. This article focuses on intraoperative techniques available to limit bleeding, thereby minimizing pain and the need for postoperative transfusion.

[1]  S. Tarabichi,et al.  Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. , 2011, The Journal of arthroplasty.

[2]  M. Bigdeli,et al.  The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. , 2013, Orthopedics.

[3]  T. Errico,et al.  A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery , 2010, BMC surgery.

[4]  V. Goldberg,et al.  Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. , 2009, American journal of orthopedics.

[5]  G. Stoddard,et al.  Reduced blood loss after total knee arthroplasty with local injection of bupivacaine and epinephrine. , 2009, The journal of knee surgery.

[6]  J. Douketis,et al.  Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. , 2009, Thrombosis research.

[7]  C. Doria,et al.  Topical hemostasis: a valuable adjunct to control bleeding in the operating room, with a special focus on thrombin and fibrin sealants , 2009, Expert opinion on biological therapy.

[8]  Wesley K. Lew,et al.  Clinical use of topical thrombin as a surgical hemostat , 2008, Biologics : targets & therapy.

[9]  B. Eriksson,et al.  Rivaroxaban vs Enoxaparin for Thromboprophylaxis after Hip Arthroplasty , 2008 .

[10]  M. Lozano,et al.  Effectiveness and safety of tranexamic acid administration during total knee arthroplasty , 2008, Vox sanguinis.

[11]  B. Eriksson,et al.  Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. , 2008, The New England journal of medicine.

[12]  G. Walker,et al.  Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. , 2006, The Knee.

[13]  T. Seyler,et al.  Reductions in blood loss with use of a bipolar sealer for hemostasis in primary total knee arthroplasty. , 2005, Surgical technology international.

[14]  D. M. Anthony,et al.  Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. , 2003, The Cochrane database of systematic reviews.

[15]  H. Fredin,et al.  Blood conservation with tranexamic acid in total hip arthroplasty: A randomized, double-blind study in 40 primary operations , 2001, Acta orthopaedica Scandinavica.

[16]  J. Weckström,et al.  Tranexamic Acid Reduces Blood Loss in Total Hip Replacement Surgery , 2000, Anesthesia and analgesia.

[17]  M. Neo,et al.  Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties , 2000, Archives of Orthopaedic and Trauma Surgery.

[18]  C. Tauber,et al.  The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. , 1999, The Journal of bone and joint surgery. American volume.

[19]  K. Goa,et al.  Tranexamic acid: a review of its use in surgery and other indications. , 1999, Drugs.